Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Ann Allergy Asthma Immunol ; 127(4): 451-455.e1, 2021 10.
Artículo en Inglés | MEDLINE | ID: covidwho-1275118

RESUMEN

BACKGROUND: Oral immunotherapy (OIT) is effective in desensitizing patients with food allergy but adverse reactions limit its use. OBJECTIVE: To study the effect of the coronavirus disease 2019 lockdown in Israel between March 15, 2020, and April 30, 2020, on the incidence of home epinephrine-treated reactions. METHODS: All patients who were in the up-dosing phase of OIT for greater than or equal to 1 month during the lockdown, or a respective period in years 2015 to 2019, were studied. The incidence of home-epinephrine treated reactions during the 2020 lockdown was compared with that in the respective period in 2015 to 2019 and to periods before and after the lockdown. RESULTS: A total of 1163 OIT treatments were analyzed. Two epinephrine injections occurred during 2020 (0.7%) compared with 29 injections (3.28%) during 2015 to 2019 (P = .03). Patients treated in 2020 were older (8.1 vs 7 years, P < .01) and had a significantly lower single highest tolerated dose (12 vs 20 mg protein, P < .01). The rate of milk-OIT was lower (P = .01), but the total number of milk treatments was higher (99 vs 71 to 82) in 2020 compared with 2015 to 2019. On multivariate analysis, treatments during the 2020 lockdown were performed in older patients (P = .001), primarily for nonmilk (P = .03), began with a lower single highest tolerated dose (P = .006), and were associated with significantly less home epinephrine-treated reactions (P = .05) compared with those in 2015 to 2019. Patients treated in 2020 experienced more epinephrine-treated reactions in adjacent periods before (n = 8) and after (n = 6) the lockdown. CONCLUSION: The lower rate of home epinephrine-treated reactions during the coronavirus disease 2019 lockdown in Israel suggests that potentially avoidable triggers contribute significantly to the rate of adverse reactions during OIT.


Asunto(s)
Desensibilización Inmunológica/efectos adversos , Epinefrina/administración & dosificación , Epinefrina/efectos adversos , Hipersensibilidad a los Alimentos/tratamiento farmacológico , Administración Oral , Adolescente , Adulto , Alérgenos/inmunología , COVID-19/epidemiología , Niño , Preescolar , Femenino , Humanos , Masculino , SARS-CoV-2/patogenicidad , Adulto Joven
5.
J Am Acad Orthop Surg Glob Res Rev ; 4(12): e20.00100, 2020 12 15.
Artículo en Inglés | MEDLINE | ID: covidwho-983932

RESUMEN

INTRODUCTION: Wide-awake local anesthesia no tourniquet (WALANT) presents a nonstandard anesthetic approach initially described for use in hand surgery that has gained interest and utilization across a variety of orthopaedic procedures. In response to operating room resource constraints imposed by the COVID-19 pandemic, our orthopaedic service rapidly adopted and expanded its use of WALANT. METHODS: A retrospective review of 16 consecutive cases performed by 7 surgeons was conducted. Patient demographics, surgical details, and perioperative outcomes were assessed. The primary end point was WALANT failure, defined as intraoperative conversion to general anesthesia. RESULTS: No instances of WALANT failure requiring conversion to general anesthesia occurred. In recovery, one patient (6%) required narcotics for pain control, and the average postoperative pain numeric rating scale was 0.6. The maximum pain score experienced was 4 in the patient requiring postoperative narcotics. The average time in recovery was 42 minutes and ranged from 8 to 118 minutes. CONCLUSION: The WALANT technique was safely and effectively used in 16 cases across multiple orthopaedic subspecialties, including three procedures not previously described in the literature. WALANT techniques hold promise for use in future disaster scenarios and should be evaluated for potential incorporation into routine orthopaedic surgical care.


Asunto(s)
Anestesia Local/métodos , COVID-19 , Quirófanos/organización & administración , Procedimientos Ortopédicos , Adulto , Anciano , Anestésicos Locales/administración & dosificación , COVID-19/epidemiología , Epinefrina/administración & dosificación , Femenino , Hemostáticos/administración & dosificación , Humanos , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Narcóticos/uso terapéutico , Dolor Postoperatorio/tratamiento farmacológico , Pandemias , Estudios Retrospectivos , SARS-CoV-2 , Vasoconstrictores/administración & dosificación , Adulto Joven
6.
PLoS One ; 15(10): e0241028, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-890185

RESUMEN

INTRODUCTION: An increase in the incidence of OHCA during the COVID-19 pandemic has been recently demonstrated. However, there are no data about how the COVID-19 epidemic influenced the treatment of OHCA victims. METHODS: We performed an analysis of the Lombardia Cardiac Arrest Registry comparing all the OHCAs occurred in the Provinces of Lodi, Cremona, Pavia and Mantua (northern Italy) in the first 100 days of the epidemic with those occurred in the same period in 2019. RESULTS: The OHCAs occurred were 694 in 2020 and 520 in 2019. Bystander cardiopulmonary resuscitation (CPR) rate was lower in 2020 (20% vs 31%, p<0.001), whilst the rate of bystander automated external defibrillator (AED) use was similar (2% vs 4%, p = 0.11). Resuscitation was attempted by EMS in 64.5% of patients in 2020 and in 72% in 2019, whereof 45% in 2020 and 64% in 2019 received ALS. At univariable analysis, the presence of suspected/confirmed COVID-19 was not a predictor of resuscitation attempt. Age, unwitnessed status, non-shockable presenting rhythm, absence of bystander CPR and EMS arrival time were independent predictors of ALS attempt. No difference regarding resuscitation duration, epinephrine and amiodarone administration, and mechanical compression device use were highlighted. The return of spontaneous circulation (ROSC) rate at hospital admission was lower in the general population in 2020 [11% vs 20%, p = 0.001], but was similar in patients with ALS initiated [19% vs 26%, p = 0.15]. Suspected/confirmed COVID-19 was not a predictor of ROSC at hospital admission. CONCLUSION: Compared to 2019, during the 2020 COVID-19 outbreak we observed a lower attitude of laypeople to start CPR, while resuscitation attempts by BLS and ALS staff were not influenced by suspected/confirmed infection, even at univariable analysis.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/epidemiología , Servicios Médicos de Urgencia , Paro Cardíaco Extrahospitalario/terapia , Neumonía Viral/epidemiología , Anciano , Anciano de 80 o más Años , Amiodarona/administración & dosificación , COVID-19 , Reanimación Cardiopulmonar , Infecciones por Coronavirus/virología , Desfibriladores , Epinefrina/administración & dosificación , Femenino , Humanos , Incidencia , Italia , Estudios Longitudinales , Masculino , Pandemias , Neumonía Viral/virología , Estudios Prospectivos , Sistema de Registros , SARS-CoV-2 , Factores de Tiempo , Vasoconstrictores/administración & dosificación , Vasodilatadores/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA